Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis

NCT02214888 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: BIRB 796 BS, low dose
DRUG: BIRB 796 BS, high dose
DRUG: Placebo

Sponsor

Boehringer Ingelheim